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LYMPHATIC leukaemia has been observed following the inoculation of Friend
virus into rats (Mirand and Grace, 1962; Dawson, Rose and Fieldsteel, 1966) and
mice (Gross, 1964; Dmochowski et al., 1966). An earlier report (Dawson, Rose,
and Fieldsteel, 1966) described in detail the lymphatic leukaemia in rats and
some of the properties of the virus recovered from these animals. After 4 serial
passages in rats the virus recovered from leukaemic rats never produced Friend
disease when inoculated into mice, although many of the mice subsequently
developed lymphatic leukaemia. This raised the question of the relationship
between the virus recovered from rats with lymphatic leukaemia and the original
Friend virus. Three possibilities seemed likely: (1) that host factors had altered
the pathological response to the inoculation of Friend virus; (2) that a separate
virus, present as a contaminant in the original pools of Friend virus, had been
isolated by passage in a host resistant to Friend virus; or (3) that the lymphatic
leukaemia virus was present not as a contaminant, but as a helper virus for an
incomplete Friend virus and that in a host resistant to Friend virus, the helper
virus was isolated.
Using a combination of immunological and biological methods an attempt
has been made to resolve this problem.
MATERIALS AND METHODS
Scott-Russ rats were from our own colony which originated in Newcastle
upon Tyne, England. Sprague-Dawley rats and BALB/c mice were bought from
Simonsen Laboratories, Gilroy, California, U.S.A. Unless otherwise specified in
the text, Scott-Russ rats were used.
The origin ofour strain ofFriend virus, the derivation oflymphatic leukaemia
virus, and the standard methods used for the preparation of virus pools have
been described previously (Fieldsteel, Dawson, and Bostick, 1963; Dawson, Rose,
and Fieldsteel, 1966).
In experiments involving serial passage, newborn mice were inoculated
intraperitoneally with 0 05 ml. of a 20 % extract of the spleens under test.
Approximately 5 weeks later these mice were killed and their spleens removed
aseptically. Half of each spleen was taken for histological examination and the
remainder pooled and ground up in sucrose stabilizer to produce a 20 % extract.
This was used to inoculate newborn mice for the next passage. At certain passage
levels, animals were kept up to 203 days to determine if the lymphatic leukaemia
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Ether treatment was carried out by mixing ethyl ether (reagent grade) with
the virus preparation to give a final concentration of either 25 or 50 %. The
mixture was kept at 40 C. for 24 hours with periodical vigorous shaking. Ether
was removed by bubbling dry nitrogen through the chilled mixture until the
volume was reduced to that of the original virus and the preparation then was
clarified by low speed centrifugation. This was either inoculated at once or
quick-frozen and stored at -70 C. until use a few days later. Control prepara-
tions were kept at 40 C. for 24 hours and then similarly exposed to nitrogen.
Neutralization tests
The antigens employed are listed in Table I. All antisera (denoted in the
text by the prefix X) were prepared in adult rats. Adult animals were used
because they do not develop leukaemia following inoculation of the Friend and
lymphatic leukaemia viruses used as antigens. Normal rats were bled to obtain
normal serum (NRS) and 14 days later were inoculated intraperitoneally with
1 ml. of a mixture of equal parts of antigen and complete Freund's adjuvant.
Additional doses of 0 5 ml. of antigen were given subcutaneously 21, 42, and 66
days later. The rats were bled 52 days after the first dose of antigen and again
24 days later. In some instances they were given another dose of antigen and
bled again. The serum obtained from the various bleedings was inactivated at
560 C. for one-half hour, and stored in small aliquots at -20° C.
Virus neutralization tests were carried out using a constant serum-variable
virus method. Serial tenfold dilutions of virus were made in sucrose stabilizer.
These were mixed with an equal volume of undiluted serum, and incubated for
1 hour at 370 C. Rats aged 3 days or less received 0 1 ml. of the mixture intra-
peritoneally, and young adult mice were given 0 2 ml. intraperitoneally. Animals
inoculated with lymphatic leukaemia virus were observed for 180 days and
animals inoculated withFriend virus for 35 days, although any that were moribund
were killed earlier. Deaths in young rats within 30 days of inoculation were
considered to be nonspecific. The diagnosis of leukaemia was based on gross
appearances where this was obvious and histological evidence where it was not.
Virus titres were calculated by the method ofReed and Muench and neutralization
indices determined.
Immunodiffusion tests
The antigens and antisera used in the immunodiffusion tests were the same
as those used in the neutralization tests (see Table I). Antigens were concentrated
fivefold before use; this concentration was halved in experiments using absorbed
antisera. After clarification at 5000 r.p.m. for 30 minutes, the tissue extracts
were centrifuged at 22,000 r.p.m. for 90 minutes. The supernatant was then
discarded and the pellet resuspended in one-fifth the original volume of sucrose
stabilizer. Concentrated antigen was stored in 0 5 ml. amounts at
- 70° C.
until needed. In some gel diffusion experiments the sera were absorbed to
remove nonspecific and specific antibodies. Cell suspensions were obtained
from the spleens of either freshly killed normal animals or mice with Friend
disease, from the spleens and thymuses of mice with lymphatic leukaemia, and
from the thymuses of rats with lymphatic leukaemia. Fresh sheep red blood
cells were obtained commercially. All cells were washed 6 times with ice-cold
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TABLE I.-Antigens
LLV = 20% extract of thymus and lymph node from the 5th and 6th passages of
lymphatic leukaemia virus in Scott-Russ rats.
LLVE = 20% extract ofthymus and lymph node from Scott-Russ rats inoculated with
ether-treated lymphatic leukaemia virus from the 5th rat passage.
LLVM = 20% extract ofspleen, lymph node, and thymus fromBALB/c mice inoculated
with lymphatic leukaemia virus from the 7th passage in Scott-Russ rats.
This had been ether-treated at the 5th passage.
FV = 20% extract of spleen from the 9th passage of Friend virus in BALB/c mice.
FVA = 20% extract of spleen from BALB/c mice inoculated with preparations of
Friend virus that had been absorbed with antiserum to lymphatic leukaemia
virus.
NR = 20% extract of thymus, liver, and spleen from normal Scott-Russ rats.
NM = 20% extract of thymus, liver, and spleen from normal BALB/c mice.
The prefix X is used in the text to denote the corresponding antiserum prepared in
Scott-Russ rats.
phosphate buffered saline. The sera were absorbed 3 times with an equal volume
of packed cells for 1 hour at room temperature. After the final absorption, the
serum was separated by centrifugation and stored at -20° C.
Preliminary experiments showed that optimum precipitin bands were obtained
in 0 8 % ionagar (Oxoid Ionagar No. 2 obtained from Colab Laboratories, Inc.,
Chicago Heights, Illinois) in pH 8 0 barbital/HCl buffer. A double diffusion
system with S depots was used. The wells measured 4 mm. in diameter and
the distance between their centres was either 8 or 10 mm. The wells were initially
recharged daily for 6 days, but in later experiments a constant-feeding system
was used without any detectable differences in the results. The plates were kept
at room temperature and observed for 10 days.
RESULTS
Since early passage lymphatic leukaemia virus obtained from rats also induced
Friend disease it was necessary to be certain that biologically active Friend
virus was absent from the latter passages to be employed in the serological studies.
This was done by serial blind passage in newborn BALB/c mice. Lymphatic
leukaemia virus preparations tested in this way were from the fifth and sixth
passage in rats (LILV) as well as from the fifth rat passage that had been exposed
to ether and passed twice more in rats (LLVE). The results ofthese experiments
are detailed in Table II. None ofthe virus preparations produced Friend disease
in the highly susceptible newborn BALB/c mice, although all induced lymphatic
leukaemia in them.
Initially a series of cross-neutralization tests were carried out using antiserum
to lymphatic leukaemia virus and Friend virus respectively. The results (Table
III) indicate a significant degree of cross-neutralization of both Friend virus and
lymphatic leukaemia virus by the 2 antisera. While these results could be
taken to indicate that the 2 virus preparations were antigenically identical and
that the 2 types of leukaemia produced were manifestations of a single virus
acting under the influence of host or other factors, they would also be consistent
with the idea that " Friend virus " was a mixture of 2 immunologically related
viruses.
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TABLE II.-Attempted Isolation ofFriend Virus8 in Newborn BALB/c
Micefrom Various RatPassaged Virus Preparations
Previous passage history
5 passages in Scott-Russ rats
6 passages in Scott-Russ rats
5 passages in Scott-Russ rats fol-
lowed by ether treatment
*
t
Passages
in newborn
mice
1
2
3
4
5
6
1
2
3
4
5
6
1
2
3
4
5
6
Age at
sacrifice
or death*
44§
72-102
37§
32§
29§
32-35§
60-105
39
63-113
39§
74-203
31-39§
36-37§
37§
33§
83-114
36-37
128-186
35§
56-80
37§
37§
29-35§
35§
97-110
40
70-130
Results of blind passage
1 A-
Number Number Number
with FDt with LL$ inoculated
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
0
7
0
7
1
7
0
0
0
0
2
1
1
0
14
0
0
2
1
2
1
4
6
13
12
10
6
9
7
12
9
8
11
10
13
7
7
6
14
5
7
15
10
17
16
4
5
11
4
Days.
Friend disease.
Lymphatic leukaemia.
All spleens from mice in these groups were pooled and extracts used for the next passage.
TABLE III.-Results of Cross Neutralization Tests Between Lymphatic
Leukaemia Virus (LLV) and Friend Virus (FV)
Test animal
Newborn rats.
Young adult mice
Virus Serum
LLV . NRS
XLLV
LLV . NRS
XFV
LLV* . NRS
XLLV
LLV* . NRS
XFV
FV . NRS
XLLV
FV . NRS
XFV
* Because of its high titre a virus preparation that had been alternately passed in rate and mice
was used. This had also been shown to be free of biologically detectable Friend virus.
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Titre/ml
(-log10) >5.3
2-8
4-9
2-6
5X2
1-2
4-3
2-0
4-1
1-4
4-6
1-3
Neutralization
index
(log1o)
>2-5
2-3
4.0
2-3
2-7
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Although it appeared that the lymphatic leukaemia virus was free from
Friend virus, further efforts were made to ensure that this was so. The results
of a number of experiments (Table IV) indicated a difference in the response of
TABLE IV.-Effect ofTreatment with Ether on the Viability ofFriend and
Lymphatic Leukaemia Viruses
Time to Results
death or --
Animals Treat- sacrifice Friend Lymphatic Total
Virus (age) Inoculum ment (days) disease leukaemia inoculated
Friend Mice Spleen* Ether 435-440 . 0 0 10
(nb) None 34-37 7 0 7
Mice Spleen* Ether 60-519 0 0 30
(ya) None 39-53 30 0 30
Thymus* Ether 60 0 0 20
None . 41-53 20 0 20
Rats Spleen* Ether 450 0 0 13
(nb) None 120-260 0 8 13
Lymphatic . Rats Thymust . Ether 95-293 0 2 8
leukaemia (nb) None 90-180 . 0 9 9
Mice Thymust Ether 171-475 . 0 3 9
(ya) None 83-145 0 6 9
* From 8th, 9th, and 10th passages in BALB/c mice.
t From 4th and 5th passages in Scott-Russ rate.
nb = newborn.
ya = young adult.
Friend virus and lymphatic leukaemia virus to ether treatment. None of 60
mice inoculated with ether-treated Friend virus developed disease, whereas 5 of 17
rats and mice inoculated with ether-treated lymphatic leukaemia virus developed
lymphatic leukaemia. It was clear, however, from the low incidence of disease
and the prolonged latent period that the ether inactivated most of the lymphatic
leukaemia virus. Thymic extracts were prepared from leukaemic rats which
had received ether-treated virus, and 2 further passages made in rats. Similar
extracts from leukaemic rats in the latter of these passages were then exposed
to ether. Fourteen of 15inoculatedrats developed lymphatic leukaemia compared
with 6 of 7 rats receiving untreated material. If Friend virus was indeed mixed
with lymphatic leukaemia virus it might be expected that after treatment with
ether it would still induce lymphatic leukaemia. Possibly because the titre of
lymphatic leukaemia virus in Friend virus was low, none of 13 rats inoculated
with ether-treated Friend virus developed lymphatic leukaemia. Since the titre
of lymphatic leukaemia virus was greatly increased following a single passage in
rats, a thymic extract from Sprague-Dawley rats inoculated with Friend virus
was exposed to ether. Following intraperitoneal inoculation into newborn mice,
6 developed lymphatic leukaemia and 2 Friend disease, whereas among 18 mice
receiving untreated material, 17 developed Friend disease and only 1 developed
lymphatic leukaemia.
Since preparations of lymphatic leukaemia virus were available that did not
induce Friend disease in mice, attempts were made to obtain preparations of
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Friend virus that would not induce lymphatic leukaemia in rats. If 2 similar,
but not identical, agents were involved, it might be possible to absorb out
lymphatic leukaemia virus from preparations of Friend virus. Decimal dilutions
of Friend virus (FV) were incubated with fourfold dilutions of XLLV for 1 hour
at 370 C. Each dilution was inoculated into groups of 6 young adult BALB/c
mice. The mice were killed 35 days later and a cell-free extract made from the
spleens of the mice receiving the mixture containing the lowest dilution of anti-
serum and the highest dilution of virus that induced splenomegaly. This virus
was subjected to 2 additional neutralization procedures, one with XLLV and
the other with XLLVE with an intermediate passage in mice to raise the titre
of virus. Finally, the virus was passaged 3 times in adult BALB/c mice. The
final pool ofviruswasdesignatedFVA. Thismaterialwassubsequentlyinoculated
into 20 newborn rats, 9 of which developed lymphatic leukaemia with a mean
age to death of 182 days, indicating that FVA retained the property of inducing
lymphatic leukaemia in rats.
It seemed advisable to repeat the cross-neutralization tests to determine if
either the ether treatment or the serological procedure had altered the relationship
between the 2 viruses. Using these 2 preparations of virus (LLVE and FVA)
a second series of cross-neutralization tests was carried out in newborn rats and
young adult mice (Table V). Again there was significant cross-neutralization of
TABLE V.-Results of Cross Neutralization Tests between Ether Treated
Lymphatic Leukaemia Virus (LLVE) and Absorbed Friend Virus (FVA)
Neutralization
Titre/ml index
Test animal Virus Serum (-logl0) (log1o)
Newborn rats LLVE XNR 5-3 >3-6
XLLVE . <1*7
LLVE . XNM 5.3 . 2 9
XFVA 2*4
Adult mice. LLVE . XNM 4-8 13
XFVA 3.5
FVA . XNR 4.7 . >3'0
XLLVE . <17
FVA . XNM 4-4 2*2
XFVA 2*2
Friend virus by antiserum to lymphatic leukaemia. While antiserum to Friend
virus significantly neutralized lymphatic leukaemia virus when the test was
performed in newborn rats, the results of the tests in mice were equivocal, possibly
because the titre ofthe antiserum was low.
In an effort to obtain more data on the antigenic relationship between the 2
viruses, the available antigens and antisera were tested for precipitating antibodies
EXPLANATION OF PLATE
Fm. 1 (a). Centre depot XLLV absorbed with normal rat thymus cells; 12 o'clock NR;
2 o'clock NM; 5 o'clock LLVM; 7 o'clock FV; 10 o'clock LLVE . (b) Centre depot XFV
absorbed with normal mouse spleen cells. The contents of the other depots are the same
as in Fig. la.
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using a double diffusion microtechnique. Many experiments were performed
using several different batches of antisera.
Antiserum to lymphatic leukaemia virus consistently produced at least 2
precipitin bands of identity when tested against Friend virus and lymphatic
leukaemia virus (Fig. la). Lymphatic leukaemia virus preparations derived from
either rats or mice reacted similarly. The precipitin bands were removed by
absorption with cells from rats or mice with lymphatic leukaemia and from mice
with Friend disease, but were not removed by absorption with similar cells from
normal rats or mice.
The reactions obtained with antiserum to Friend virus were less consistent
and harder to interpret, possibly because the antigen was derived from mice and
so contained much heterologous protein. When tested against Friend virus and
lymphatic leukaemia virus, there was one discrete precipitin band of identity
(the innermost band in Fig. lb) as well as several nonspecific bands. The former
was removed by absorption with cells from rats or mice with lymphatic leukaemia
and mice with Friend disease, but not by normal rat or mouse cells. Antisera
prepared to normal rat and mouse tissue did not react with any of the viral
antigens under the conditions of the experiment.
The immunodiffusion tests confirm the presence of an antigenic relationship
between the 2 viruses. However, additional work using highly purified antigens
(which are not presently available) will be required to determine the exact number
and nature of the antigens concerned.
DISCUSSION
The question whether one virus can induce more than one type of leukaemia
is fundamental in leukaemogenesis. In our studies 2 distinct types of disease
were induced which differed not only in cell type, but also in the latent period
and organs involved (Dawson, Rose and Fieldsteel, 1966). In all but an occasional
instance a pathological diagnosis could be made without hesitation. In equivocal
cases the correct diagnosis could usually be resolved by passage of tissue from
the mouse in question into young adult mice, since Friend virus when present
induced massive splenomegaly in 3 to 4 weeks. The difference in the susceptibility
to either of the 2 agents was largely relative and appeared to depend in part on
the source of the virus.
Despite the apparent biological differences, serological tests involving both
neutralizing and precipitating antibodies have revealed an antigenic relationship
between the 2 viruses. This might suggest that one agent operating under the
influence of host factors was producing both types of disease. If this were so,
it is difficult to understand why after many years of passage in mice Friend virus
invariably induces lymphatic leukaemia in rats. Yet the same agent after only
4 or 5 passages in rats is incapable of inducing Friend disease when passed again
in mice. A second explanation is that Friend virus is a mixture of 2 viruses
bearing an antigenic relationship similar to that existing between the Moloney
and Friend viruses (Old, Boyse and Stockert, 1964; Fink, Rauscher and Chirigos,
1966). A more attractive explanation is that Friend virus is defective and
depends upon the presence of the lymphatic leukaemia virus which acts as a
helper. This would explain both the close antigenic relationship between the
2 viruses and our inability to obtain a preparation of Friend virus from which
the lymphatic leukaemia virus could not be recovered.
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SUMMARY
The relationship has been investigated between Friend virus and an associated
virus that induces lymphatic leukaemia. In addition to the pathological
differences in the type of disease produced, a difference in their resistance to ether
was observed. Cross-neutralization and immunodiffusion tests showed a close
antigenic relationship between Friend virus and the lymphatic leukaemia virus.
Strains of lymphatic leukaemia virus were established by serial passage in rats
and by ether treatment which failed to induce Friend disease after serial blind
passage in BALB/c mice. However, attempts to remove the lymphatic leukaemia
component from Friend virus were unsuccessful.
This work was supported by a grant from the American Cancer Society,
Oregon Division (P. J. D.) and USPHS grant No. CA-07868 from the National
Cancer Institute (A. H. F.).
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